Deals

Synphatec Completes Over USD 50 Million Series A to Advance CNS Pipeline – Rapid‑Acting Antidepressant SP-101 and Alzheimer's Gene Therapy SP-201 Enter Next Development Phase
Synphatec

Synphatec Completes Over USD 50 Million Series A to Advance CNS Pipeline – Rapid‑Acting Antidepressant SP-101 and Alzheimer’s Gene Therapy SP-201 Enter Next Development Phase

Synphatec, a clinical‑stage biotechnology company focused on next‑generation therapies for central nervous system (CNS) disorders, announced the completion of a Series A financing of over USD 50 million, with proceeds…

Earendil Labs Strikes Bispecific Antibody Deal with Genentech – $55 Million Upfront, Total Value Tops $1.5 Billion in Oncology

Earendil Labs Strikes Bispecific Antibody Deal with Genentech – $55 Million Upfront, Total Value Tops $1.5 Billion in Oncology

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Illumina and Tempus AI Collaborate to Advance Next-Generation Sequencing in Clinical Practice
AIIllumina

Illumina and Tempus AI Collaborate to Advance Next-Generation Sequencing in Clinical Practice

Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device
FinanceJunion Therapeutics

Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device

Eli Lilly BigHat Biosciences Machine Learning Platform
ADC / XDCBigHat Biosciences

Eli Lilly Collaborates with BigHat Biosciences to Engineer Advanced Therapeutic Antibodies

Akeso Biopharma Partners with Virogin to Test Ivonescimab and VG201 in Colorectal Cancer Trial
Combination therapyHKG: 9926

Akeso Biopharma Partners with Virogin to Test Ivonescimab and VG201 in Colorectal Cancer Trial

Show More